Amy Tenderich was diagnosed with type 1 diabetes in May of 2003. She is the founder and editor-in-chief of Diabetes Mine and co-authored the book Know Your Numbers, Outlive Your Diabetes. You will frequently find her speaking at diabetes, health, and social media events across the country.
This is a bonus tip for people with type 1 diabetes. Symlin is an additional glucose-lowering drug prescribed mainly to type 1 diabetics already taking insulin.
A few years ago a company called Amylin Pharmaceuticals introduced the first new “high-impact” medication for type 1 diabetics since the advent of insulin. A cousin to Byetta, this drug is called Symlin, and is taken as a shot – along with insulin – at mealtimes to counteract the BG spikes that diabetics experience after eating (known as high “postprandial” BG levels).
Symlin is actually a replacement for amylin, a hormone present in the pancreas of people without diabetes, that helps the body's metabolism properly regulate itself.
Scientists realized that not only was insulin missing in people with type 1 diabetes, but this hormone as well. The drug is still fairly new on the market, but has been shown to help patients significantly in better managing their BG levels.
So why isn’t everyone with type 1 diabetes taking Symlin? Review the pros and cons below.
- Reduces or eliminates the BG peaks after meals and snacks that are so troublesome for us diabetics. (Remember, it’s the cumulative effects of these peaks that cause damage to your nerves, eyes, kidneys, and cardiovascular system over time.)
- Extra help reducing post-meal peaks can be very important for patients who are struggling, or seeking extra-tight control, for example during pregnancy.
- Allows patients to reduce their insulin doses.
- Acts as an appetite suppressant, since it slows stomach emptying.
- It’s known to cause lingering nausea (similar to Byetta, its injectable cousin for treating type 2 diabetes).
- Requires extra injections! Patients need to take insulin AND Symlin shots before each meal.
- Balancing doses of Symlin and insulin can be very tricky: the combo can lead to severe hypoglycemia (low blood sugar), so it’s also not appropriate for anyone who is hypoglycemia unaware.